Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 897

1.

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

Detels R, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP.

JAMA. 1998 Nov 4;280(17):1497-503.

PMID:
9809730
[PubMed - indexed for MEDLINE]
2.

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.

de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, Pezzotti P.

JAMA. 2000 Jul 12;284(2):190-7.

PMID:
10889592
[PubMed - indexed for MEDLINE]
3.

Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.

Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P.

Int J Epidemiol. 1998 Apr;27(2):289-95.

PMID:
9602412
[PubMed - indexed for MEDLINE]
Free Article
4.

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category.

Pérez-Hoyos S, del Amo J, Muga R, del Romero J, García de Olalla P, Guerrero R, Hernàndez-Aguado I; GEMES (Spanish Multicenter Study Group of Seroconverters).

AIDS. 2003 Feb 14;17(3):353-9.

PMID:
12556689
[PubMed - indexed for MEDLINE]
5.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A.

JAMA. 1999 Dec 15;282(23):2220-6.

PMID:
10605973
[PubMed - indexed for MEDLINE]
6.

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.

Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS.

JAMA. 2001 Nov 28;286(20):2568-77.

PMID:
11722271
[PubMed - indexed for MEDLINE]
7.

Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.

Graham NM, Hoover DR, Park LP, Stein DS, Phair JP, Mellors JW, Detels R, Saah AJ.

Ann Intern Med. 1996 Jun 15;124(12):1031-8.

PMID:
8633816
[PubMed - indexed for MEDLINE]
8.

[Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].

Pezzotti P, Dorrucci M, Donisi A, Cusini M, Mazzarello G, De Luca A, Salassa B, Ursitti MA, Giuliani M, Rezza G; l'Italian Seroconversion Study.

Epidemiol Prev. 2003 Nov-Dec;27(6):348-55. Italian.

PMID:
15058363
[PubMed - indexed for MEDLINE]
9.

How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee.

[No authors listed]

AIDS. 1999 Jul 9;13(10):1241-7.

PMID:
10416529
[PubMed - indexed for MEDLINE]
10.

Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts.

Tarwater PM, Mellors J, Gore ME, Margolick JB, Phair J, Detels R, Muñoz A.

Am J Epidemiol. 2001 Oct 1;154(7):675-81.

PMID:
11581102
[PubMed - indexed for MEDLINE]
Free Article
11.

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

JAMA. 1998 Feb 11;279(6):450-4.

PMID:
9466638
[PubMed - indexed for MEDLINE]
12.

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

CMAJ. 1999 Mar 9;160(5):659-65.

PMID:
10102000
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL.

JAMA. 2002 Jul 10;288(2):199-206.

PMID:
12095384
[PubMed - indexed for MEDLINE]
14.

Survival from early, intermediate, and late stages of HIV infection.

Enger C, Graham N, Peng Y, Chmiel JS, Kingsley LA, Detels R, Muñoz A.

JAMA. 1996 May 1;275(17):1329-34.

PMID:
8614118
[PubMed - indexed for MEDLINE]
16.

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

Anastos K, Barrón Y, Miotti P, Weiser B, Young M, Hessol N, Greenblatt RM, Cohen M, Augenbraun M, Levine A, Muñoz A; Women's Interagency HIV Study Collaborative Study Group.

Arch Intern Med. 2002 Sep 23;162(17):1973-80.

PMID:
12230420
[PubMed - indexed for MEDLINE]
17.

Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection.

Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV.

J Acquir Immune Defic Syndr. 2002 May 1;30(1):81-7.

PMID:
12048367
[PubMed - indexed for MEDLINE]
18.

Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.

Rezza G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17 Suppl 1:S13-6.

PMID:
9586645
[PubMed - indexed for MEDLINE]
19.

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe) Collaboration.

HIV Med. 2000 Oct;1(4):224-31.

PMID:
11737353
[PubMed - indexed for MEDLINE]
20.

The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.

Hendriks JC, Satten GA, van Ameijden EJ, van Druten HA, Coutinho RA, van Griensven GJ.

AIDS. 1998 Aug 20;12(12):1537-44.

PMID:
9727576
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk